MedTrace Logo

Comparison of Two Norepinephrine Bolus Doses for Management of Post-spinal Hypotension During Cesarean Delivery

NCT03792906 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2021-09-24

No results posted yet for this study

Summary

In this study the investigators will compare two doses of norepinephrine bolus (6 mcg and 10 mcg) in management of maternal hypotensive episode after subarachnoid block during Cesarean delivery.

Conditions

  • Cesarean Section Complications
  • Spinal Anesthetic Toxicity

Interventions

DRUG

Norepinephrine 6 mcg

An intravenous bolus of norepinephrine 6 mcg will be administered for management of maternal hypotension.

DRUG

Norepinephrine 10 mcg

An intravenous bolus of norepinephrine 10 mcg will be administered for management of maternal hypotension.

DRUG

Norepinephrine infusion

Prophylactic norepinephrine infusion will be started after subarachnoid block.

DRUG

Bupivacaine hydrochloride

Subarachnoid block will be performed using Bupivacaine hydrochloride (2.2 mL) in addition to fentanyl 25 mcg.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Ahmed M Hasanin, Professor · Assistant professor of anesthesia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-18
Primary Completion
2019-04-25
Completion
2019-05-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03792906 on ClinicalTrials.gov